Social Check-up for Pharma
In 2015 I interviewed Becky Canvin and Rick Evans of Ogilvy Healthworld about the state of Pharma and Social Media. The results reflected an industry that was cautious, risk-adverse and a little stiff. A lot has changed in the Pharma Social Media world with more Pharma companies embracing social media. In light of this growth in the use of social media, the team at Ogilvy Healthworld joined me for a conversation about what has changed and what additional factors they examined.
Joining my original guests, Becky and Rick are Philippa McClure, Sr. Account Manager with Ogilvy Healthworld and from Pulsar, Sameer (Sam) Shah.
Join our conversation and be sure to check out the report via the links below.
- Slideshare: http://www.slideshare.net/OgilvyCommonHealth/the-social-checkup
- Ogilvy Healthworld: [email protected]
- Pulsar: [email protected]
- Hashtag: #SocialCheckUp
About the Social Check-up
The Social Check-up is a thought-leadership series, brought to you by Ogilvy Healthworld in partnership with Pulsar. Combining Ogilvy’s strategic expertise with Pulsar’s cutting edge data platform, The Social Check-up explores the latest trends in healthcare and pharmaceutical social media.
About Ogilvy Healthworld
Ogilvy Healthworld is an expert health communications community. We build social strategies and programmes to change health behaviors; ultimately inspiring better health outcomes based on our strong scientific, social media and healthcare expertise.
- Website: www.ogilvychww.com
- Instagram: @Ogilvyuk
- Twitter: @OgilvyHWUK
About Pulsar
Pulsar’s software platform allows you to understand any audience, market, trend or conversation in great detail. An incredibly powerful tool that helps you solve a wide range of marketing challenges. Pulsar is available as a subscription to set up your own searches, or through our experienced team of researchers who can deliver the insights for you.
- Website: www.pulsarplatform.com
- Email: [email protected]
- Facebook: Pulsar Social
- Twitter: @Pulsar_Social